Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001593318-14-000001
Filing Date
2014-07-25
Accepted
2014-07-24 17:37:12
Documents
1
Effectiveness Date
2014-07-25
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9140
  Complete submission text file 0001593318-14-000001.txt   10231
Mailing Address 260 LITTLEFIELD AVENUE SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650) 235-4140
Reset Therapeutics, Inc. (Filer) CIK: 0001593318 (see all company filings)

EIN.: 711047315 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-221749 | Film No.: 14992179